The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A randomized controlled trial evaluating efficacy of adjuvant oral uracil-tegafur (UFT) with leucovorin (LV) after resection of colorectal cancer liver metastases: The UFT/LV study.
Akira Kobayashi
Honoraria - Chugai Pharma; Daiichi Sankyo; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Kiyoshi Hasegawa
Honoraria - Eisai; Merck Serono
Akio Saiura
Honoraria - Bristol-Myers Squibb; Merck Serono; Taiho Pharmaceutical; Yakult Honsha
Tadatoshi Takayama
No relevant relationships to disclose
Shinichi Miyagawa
No relevant relationships to disclose
Junji Yamamoto
No relevant relationships to disclose
Yasutsugu Bandai
No relevant relationships to disclose
Masanori Teruya
No relevant relationships to disclose
Fuyo Yoshimi
No relevant relationships to disclose
Seiji Kawasaki
No relevant relationships to disclose
Hiroto Koyama
No relevant relationships to disclose
Masaru Oba
No relevant relationships to disclose
Michiro Takahashi
No relevant relationships to disclose
Nobuyuki Mizunuma
No relevant relationships to disclose
Yutaka Matsuyama
No relevant relationships to disclose
Toshiaki Watanabe
Consultant or Advisory Role - Bristol-Myers Squibb; Chugai Pharma; Merck Serono; Takeda; Yakult Honsha
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Bristol-Myers Squibb; Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Masatoshi Makuuchi
No relevant relationships to disclose
Norihiro Kokudo
Honoraria - Chugai Pharma; Merck Serono; Taiho Pharmaceutical
Research Funding - Chugai Pharma; Merck Serono; Taiho Pharmaceutical